Company: PTPI
Filing Date: 2025-03-07
Form Type: PRE 14A
Source: 0001104659-25-021794
Chunk: 20

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-07
Form: PRE 14A
Chunk 20
---
 warrants subject to a 4.99% beneficial ownership blocker), and (ii) 136.19 shares of Series A
Preferred Stock, convertible into up to approximately 567,458 shares of Common Stock within 60 days of the Record Date (subject to a
4.99% beneficial ownership blocker).

Mr. Kopin and Mr. Asher are each managers of Intracoastal
and have shared voting control and investment discretion over the securities reported herein that are held by Intracoastal. As a result,
each of

Mr. Kopin and Mr. Asher may be deemed to have beneficial
ownership (as determined under Section 13(d) of the Exchange Act of the securities reported herein that are held by Intracoastal
Capital LLC. The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483 and the principal
business office of Mr. Asher is 111 W. Jackson Boulevard, Suite 2000, Chicago, Illinois 60604.

(6) Based on certain information made available to the Company.
Represents (i) 1,250,000 shares of Common Stock, (ii) 6,250,004 shares of Common Stock issuable upon exercise of certain warrants
that were exercisable as of the Record Date or will be exercisable within 60 days thereafter (subject to a 4.99% beneficial ownership
blocker), (iii) 2,916,664 shares of Common Stock issuable upon exercise of the Pre-Funded Warrants (subject to a 4.99% beneficial
ownership blocker), and (iv) 36.90 shares of Series A Preferred Stock, convertible into up to approximately 153,750 shares of
Common Stock within 60 days of the Record Date (subject to a 4.99% beneficial ownership blocker).

<div align='center'>13</div>

Messrs. Arie Rabinowitz and Joe Hammer have voting and investment
control over the securities held by Five Narrow Lane LP. Five Narrow Lane LP’S address is 510 Madison Avenue, Suite 1400,
New York, NY 10022.

(7) Based on certain information made available to the Company.
Represents (i) 1,250,000 shares of Common Stock, (ii) 5,833,332 shares of Common Stock issuable upon exercise of certain warrants
that were exercisable as of the Record Date or will be exerc